Human Pathology
Volume 41, Issue 10 , Pages 1486-1494, October 2010

The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms

  • David M. Dorfman, MD, PhD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Jason L. Hornick, MD, PhD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
  • ,
  • Aliakbar Shahsafaei, MS

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA
    • Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
  • ,
  • Gordon J. Freeman, PhD

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    • Department of Medicine, Harvard Medical School, Boston, MA 02115, USA

Received 9 December 2009; received in revised form 1 April 2010; accepted 2 April 2010. published online 26 July 2010.

Summary 

The T cell immunoglobulin mucin (TIM) proteins are a family of cell surface phosphatidyserine receptors that are important for the recognition and phagocytosis of apoptotic cells. Because TIM-4 is expressed by macrophages and dendritic cells in human tissue, we examined its expression in a range of histiocytic and dendritic cell neoplasms and found moderate to strong immunohistochemical staining in cases of juvenile xanthogranuloma and histiocytic sarcoma, and lower level staining in interdigitating dendritic cell sarcoma, Langerhans cell histiocytosis, acute monocytic leukemia (leukemia cutis), and blastic plasmacytoid dendritic cell neoplasm (hematodermic tumor). TIM-3 was first described on activated TH1 cells but was recently shown to also be a phosphatidylserine receptor and mediate phagocytosis. We found TIM-3 was expressed by peritoneal macrophages, monocytes and splenic dendritic cells. We found that it, like TIM-4, is expressed in a range of histiocytic and dendritic cell neoplasms, typically with strong immunohistochemical staining. Cases of diffuse large B cell lymphoma, anaplastic large cell lymphoma, metastatic malignant melanoma, and metastatic poorly differentiated carcinoma generally exhibited negative to minimal heterogenous staining for TIM-4 and TIM-3. We conclude that histiocytic and dendritic cell neoplasms consistently express TIM-3 and TIM-4 and that these molecules are new markers of neoplasms derived from histiocytic and dendritic cells.

Keywords: Interdigitating dendritic cell sarcoma, Follicular dendritic cell sarcoma, Juvenile xanthogranuloma, Blastic plasmacytoid dendritic cell neoplasm, Leukemia cutis, Langerhans cell histiocytosis, T cell immunoglobulin mucin protein

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0046-8177(10)00121-8

doi:10.1016/j.humpath.2010.04.005

Human Pathology
Volume 41, Issue 10 , Pages 1486-1494, October 2010